From Tech to Pharma: A Cultural Shift

This chapter explores a professional's transition from Apple in the tech sector to Eli Lilly in life sciences, contrasting the corporate cultures and timeline perspectives of both industries. It highlights the long-term focus required in pharma, the complexities of drug development, and the potential for modernization within healthcare through technology.